Rutherford Health - Appointment of Finance Director
RNS Number : 6044Q
Rutherford Health PLC
01 March 2021

Rutherford Health Plc


Appointment of Finance Director


Rutherford Health plc (AQSE: RUTH, "Group"), a healthcare group committed to providing innovative cancer care of the highest quality, announces the appointment of Marcus King as Finance Director and Executive Director of the Group with immediate effect.

Marcus King has held senior finance roles at Rutherford Health since 2016 and was appointed acting Finance Director and Company Secretary in August 2019. Prior to joining the Group, Marcus spent eleven years at Illinois Tool Works, with his tenure culminating in a global group finance leadership role responsible for 15 businesses delivering US$200m revenue per annum. Marcus is a qualified Chartered Management Accountant (ACMA, CGMA). 


Marcus Roger King is or has been a director of the following companies in the previous five years:

Current directorships and partnerships

Former directorships and/or partnerships (within the last five years)

Rutherford Estates Management Limited


There is no further information required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Apex Rulebook.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.


For more information, please contact:


Rutherford Health plc

Tel: +44 (0) 16 3381 0661

Michael Moran, Chief Executive Officer
Marcus King, Finance Director



Grant Thornton (Corporate Adviser)

Tel: +44 (0) 20 7383 5100

Colin Aaronson/ Jamie Barklem / Seamus Fricker /
George Grainger




Instinctif Partners

Tel: +44 207 457 2020

Melanie Toyne-Sewell / Jeremy Durrant / Rozi Morris /
Phil Marriage



Media House International

Tel: 07788 414 856 or 0207 710 0020

Ramsay Smith



About Rutherford Health plc


Rutherford Health Plc operates a network of Rutherford Cancer Centres which offer the latest cancer therapies including proton beam therapy. Its centre in Wales introduced proton beam therapy to the UK and was the first to treat a cancer patient with the pioneering treatment in the UK in 2018. It also has centres in ReadingNorthumberland and Liverpool. The combined centres boast a centrally networked management system which allows patients to be treated at any Rutherford centre after they have been screened.


For more information on the Rutherford Cancer Centres, please visit:

Follow the Rutherford Cancer Centres on twitter: @therutherford_c.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.